Latest News- Endocrinology Drugs Market: Diabetes drugs is expected to lead the Therapy Area segment during 2025-2029

The Endocrinology Drugs Market is being driven by Increase in incidence of endocrine disorders

The Endocrinology Drugs Market is expected to grow at a CAGR of 7.6% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 40144.1 million. The rising prevalence of obesity is linked to an increased incidence of endocrine disorders, including diabetes, hypothyroidism, and PCOS. Obesity can also be a causative factor or secondary effect for less common endocrine disorders such as Cushing syndrome and hypothyroidism. Endocrine disorders stemming from obesity can often be managed through weight loss. Additionally, obesity may manifest as disorders such as Cushing syndrome, growth hormone deficiency, testosterone deficiency, and PCOS, leading to hormonal system alterations in some patients. 

Get more information on Endocrinology Drugs Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Therapy Area
  • Diabetes drugs
  • hGH
  • Thyroid hormone disorders
  • Others
• Distribution Channel
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increase in incidence of endocrine disorders
• Promising pipeline for endocrinology
• Research in novel dosage formulations and drug delivery systems

However, the market also witnesses some limitations, which are as follows:

• Patent expiry of major endocrinology drugs
• Reimbursement challenges
• Shortage of endocrinologists

Benefits of Buying Global Endocrinology Drugs Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Endocrinology Drugs Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Endocrinology Drugs Market caters to the treatment of disorders related to the endocrine system, which produces hormones in the body. Hormones are essential for metabolism, reproduction, and maintaining a healthy balance in the body. Hormones are produced by various glands including the parathyroid, adrenals, testes, ovaries, pituitary, and hypothalamus. Imbalances in hormones can result from unhealthy lifestyle characteristics, such as work stress, cholesterol, and weight gain. Endocrinologists use various drugs like Levothyroxine Sodium Injection, Teneligliptin, Pioglitazone, and Metformin to manage hormonal imbalances associated with conditions like Type 2 diabetes. These drugs include amines, steroids, peptides, and proteins.

Market Research Overview

The Endocrinology Drugs Market, a significant segment of the global pharmaceuticals industry, encompasses companies and research organizations specializing in the development and manufacturing of generic and non-generic drugs, peptides, proteins, and veterinary medications. According to Technavio's market analysis, the global pharmaceuticals market's growth is primarily driven by demographic trends, including the increasing aging population. By 2050, approximately one-quarter of the US population and Europe's population ratio is projected to be over 60 years old. This demographic shift will lead to a substantial increase in demand for endocrinology drugs used to treat conditions related to the endocrine system, such as those affecting the parathyroid and hypothalamus glands.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/